Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover PK, safety and tolerability of intravenous vs oral brivaracetam in healthy Japanese males
jRCT2080223863Phase 1Completed
- Sponsor
- UCB
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of brivaracetam in epilepsy (3 arms), sponsored by UCB. Primary endpoints: Pharmacokinetics of brivaracetam across formulations and Safety and tolerability of single-dose brivaracetam. Started Apr 2018; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT2080223863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223863.